Skip to main content

300K Solutions

300K Solutions participates in the Public-Private Collaboration Forum in Healthcare organized by Libertad Digital

Madrid, October 28, 2025 – 300K Solutions participated last Tuesday in the Public-Private Collaboration Forum in Healthcare, organized by Libertad Digital at the Institute of Engineering of Spain.

Fernando Martín de Lara, CEO of 300K Solutions, took part in a panel discussion where he addressed the essential role of private technological innovation within the Spanish healthcare system. During his intervention, Martín de Lara emphasized the imperative need for public-private collaboration: “This collaboration must exist. It’s impossible without it, because they are the ones who have the problems that need to be solved.”

Stay updated on our activities!

Madrid, 28 de octubre de 2025 – 300K Solutions participó el pasado martes en el Foro Colaboración Público-Privada en el Sector Sanitario, organizado por Libertad Digital y celebrado en el Instituto de la Ingeniería de España.

Fernando Martín de Lara, consejero delegado de 300K Solutions, participó en una mesa redonda donde abordó el papel fundamental de la innovación tecnológica privada dentro del sistema sanitario español. Durante su intervención, Martín de Lara enfatizó la necesidad de colaboración público-privada: “Tiene que existir esa colaboración. Es imposible sin ella, porque ellos son los que tienen los problemas que hay que resolver”.

¡Mantente al día de nuestras actividades!​

One Technology. Infinite Possibilities.

DNA

RNA

PLASMA/ SERUM

BLOOD CELL FRACTION

WHOLE BLOOD

TISSUES

We are opening a collaborative space to explore and discuss potential applications of 300K technology.

Our goal is to foster knowledge exchange between researchers, clinicians and innovators interested in real-world use cases.

CONNECT, EXPLORE, AND EXCHANGE IDEAS ON 300K APPLICATIONS

Share:

More Posts

300K Solutions will be present at EHA2026

Blood-derived sample stabilization is a critical need in hematology and biomarker research. Current preservative-based solutions provide stability for only a few days, while longer storage often requires freezing—an approach that is not always feasible.
300K Solutions leverages freeze-drying technology to extend stability from days to months in blood cells and plasma/serum. This approach preserves sample integrity from collection to analysis, minimizing biomarker degradation and eliminating the need for refrigerated logistics.

Contact Us